Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Rudolph Navari

7PUBLICATIONS
11CO-AUTHORS
Autonomic nervous systemCancer therapy (excl. chemotherapy and radiation therapy)Pharmacology and pharmaceutical sciences not elsewhere classifiedChemotherapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

Sort by Publication Date:
|Aug 09, 2025
Individual patient data meta-analysis of NEPA versus aprepitant-based antiemetic regimens for preventing chemotherapy-induced nausea and vomiting.

Rudolph M Navari, Timothy Tyler, Naoki Inui

|Mar 27, 2025
NEPA (Netupitant/Palonosetron) for the Prevention of Chemotherapy-Induced Nausea and Vomiting (CINV) in Patients Receiving Highly or Moderately Emetogenic Chemotherapy Who Experienced Breakthrough CINV in Cycle 1 of Chemotherapy: A Phase II Clinical Trial.

Rudolph M Navari, Erminio Bonizzoni

|Mar 19, 2025
Nausea and vomiting in an evolving anticancer treatment landscape: long-delayed and emetogenic antibody-drug conjugates.

Yeon Hee Park, Giampaolo Bianchini, Javier Cortés

|Aug 04, 2023
Single-dose NEPA versus an aprepitant regimen for prevention of chemotherapy-induced nausea and vomiting in patients receiving moderately emetogenic chemotherapy.

Laurent Zelek, Rudolph Navari, Matti Aapro

|Apr 21, 2021
Single-dose netupitant/palonosetron versus 3-day aprepitant for preventing chemotherapy-induced nausea and vomiting: a pooled analysis.

Rudolph M Navari, Gary Binder, Erminio Bonizzoni

|Apr 01, 2021
Low-dose olanzapine, sedation and chemotherapy-induced nausea and vomiting: a prospective randomized controlled study.

Sandip Mukhopadhyay, Premnath Dutta, Sanatan Banerjee

Pageof 2

Frequent Collaborators

2 joint publications

Eric J Roeland

1 joint publications

Sandip Mukhopadhyay

1 joint publications

Timothy Tyler

1 joint publications

Naoki Inui

1 joint publications

Hirotoshi Iihara

1 joint publications

Erminio Bonizzoni

1 joint publications

Yeon Hee Park

1 joint publications

Hope S Rugo

1 joint publications

Laurent Zelek

1 joint publications

Matti Aapro

Frequent Collaborators

2 joint publications

Eric J Roeland

1 joint publications

Sandip Mukhopadhyay

1 joint publications

Timothy Tyler

1 joint publications

Naoki Inui

Top Related Videos

Acupoint Application Combined with Acupressure as an Adjunctive Therapy for Chemotherapy-Induced Nausea and Vomiting
05:56

Acupoint Application Combined with Acupressure as an Adjunctive Therapy for Chemotherapy-Induced Nausea and Vomiting

Published on : Jun 21, 2024

1.1K
See more related videos

Top Related Videos

Acupoint Application Combined with Acupressure as an Adjunctive Therapy for Chemotherapy-Induced Nausea and Vomiting
05:56

Acupoint Application Combined with Acupressure as an Adjunctive Therapy for Chemotherapy-Induced Nausea and Vomiting

Published on : Jun 21, 2024

1.1K
See more related videos